How to Return COVID-19 and Flu Vaccines — 2024-2025 Season

If you have COVID-19 or flu vaccine doses left from this past season, now is the time to return them. We’ve listed the instructions for each manufacturer below. Please note that each manufacturer has a specific deadline. Once you have returned your vaccines, please allow 4-6 weeks for processing time.

COVID-19 Vaccines

Moderna –

If customer purchased Moderna COVID-19 vaccine through www.ModernaDirect.com, please click here for directions on how to obtain a Return Authorization (RA) from Inmar. Once you receive the RA from Inmar, the customer is responsible for shipping the vaccine to Inmar. It does not need to be refrigerated. Returns must be shipped back prior to August 31, 2025.

If customer purchased the Moderna COVID-19 vaccine through a distributor, please contact the distributor for information on how to return the unused COVID-19 vaccine. Each distributor will have its own return policy and return deadlines.

Pfizer –

Please click here for directions on how to return Pfizer COVID-19 vaccines. All returns must be received prior to September 15, 2025.

Flu Vaccines

Sanofi –

Customers are eligible to return up to 15% of their shipped influenza reservation by presentation. Returns exceeding the allowable thresholds will receive a federal excise tax credit only. To get started, log in to www.VaccineShop.com and follow these simple steps:

Once logged into www.VaccineShop.com, navigate to the Returns Tab.
Select “Create a Return” from the dropdown menu.
Enter product details, quantity in doses, number of boxes requiring Return Authorization labels, and account user’s email address.
Click “Submit” to complete your Return Authorization.
Check the status of your return by clicking the “Return History” tab.

To view the quick guide, please click here. For additional assistance, you can also reference the many resources available, including VaccineShop’s Returns Help Center which has many short instructional videos such as: Help Me With My Return, What’s My Return Status Mean? or the VaccineShop Returns Quick Guide.

Please note all eligible influenza returns must be physically received by Inmar no later than July 31, 2025, otherwise credit will be given for federal excise tax only. We encourage you to send your return immediately upon expiration for timely processing.

If you have any questions or are unable to process returns on VaccineShop.com, please contact me Sanofi’s Customer Service, 1-800-VACCINE (822-2463).

Seqirus –

Customers must complete the return requests by June 15, 2025, after which the product must be received by Inmar no later than June 28, 2025.

If customer have a direct account with Inmar, they can log into their www.flu360.com account. On the right side of the screen, click on “Orders” then “Returns.” Please click here for Influenza Vaccine Returns FAQ and checklist.

If customer does not have a direct account with Inmar, please click here to download the return form.

If you have any questions, please email Amy Bullock at abullock@primarycarealliance.com or call her at (801) 369-3933.

VAXELIS is a hexavalent pediatric vaccine codeveloped by Sanofi Pasteur and Merck. VAXELIS contains DTaP, IPOL, PedvaxHIB and Hep B. It will be available to start shipping from Sanofi Pasteur’s VaccineShoppe.com sometime in June 2021. This vaccine does contain PedvaxHIB and will not need to be reconstituted.

Pricing for VAXELIS will be based on how a customer chooses to use this vaccine in his/her practice. Sanofi Pasteur has offered a base price as well as a performance price for VAXELIS.

Base pricing will be available to all PCA customers. This pricing is for offices that choose to integrate VAXELIS at one or two of the 2, 4, 6 and 12-18 month well visits but continue using Pentacel or single entity DTaP, IPOL and HIB at the other visits. Offices may choose to do this for a variety of reasons. Another customer who would qualify for the base price for VAXELIS would be an office that chooses to have a few doses of VAXELIS on hand for parents who insist on few shots for their child or for patients who have previously received VAXELIS from another office and want to continue using it.

Performance pricing will only be available to PCA customers who commit to using VAXELIS for all patients at their 2, 4 and 6 month well visits. These offices can then give Pentacel or single entity DTaP and HIB at one of the patient’s 12-18 month old well visits.

To Start Implementing VAXELIS Into A Routine Vaccine Schedule An Office Has Two Options:

Start using VAXELIS at the 2 month old well visit and then continue giving it to these patients at their 4 month and 6 month well visits. Any patient who had already received a dose or doses of Pentacel at a previous 2 month and/or 4 month old well visit could finish the 2, 4 and 6 month visits with another dose or doses of Pentacel.

Another option would be to immediately start using VAXELIS for all 2, 4 and 6 month visits and save any doses of Pentacel the clinic has left to give to patients during one of the 12-18 month visits (whenever you give the fourth dose of DTaP).

Clinics interested in receiving VAXELIS Performance Pricing, need to return the VAXELIS Commitment Letter here.

If your clinic is thinking of using VAXELIS, please contact your payers immediately to find out reimbursement rates. The CPT Code for VAXELIS is 90697. Since this vaccine was approved by the CDC and ACIP more than a year ago, some insurance companies may have put in a “place holder” reimbursement rate since it was not yet available for purchase. You will want to make sure these companies are going to review this CPT code at upcoming meetings and set a reimbursement rate that will more than cover your cost.

For pricing information, please contact Amy at abullock@primarycarealliance.com.

As a part of Sanofi Pasteur’s 2021-2022 influenza vaccine direct offer, PCA members are eligible to participate in Sanofi Pasteur’s Schedule-to-Ship program. This gives you the ability to create an influenza vaccine shipment schedule, customize order size and shipment frequency, and manage reservations for the upcoming season according to expected patient demand.

Please Follow The Three Simple Steps Below To Create Your Own Influenza Vaccine Shipment Schedule:

Log into VaccineShoppe.com to review your confirmed influenza vaccine reservation.
Schedule your shipments online through your reservation page on VaccineShoppe.com.
- Choose a preferred shipment frequency for each presentation within the pre-determined commitment percentages per month. You can create shipment schedules for the full influenza season.
- Review and adjust your shipment schedule to best fit your immunization plan.
You will have until June 18, 2021, to create your influenza vaccine shipment schedule.

For Additional Information Regarding How To Access And Utilize Sanofi Pasteur’s 2021-2022 Schedule-To-Ship Program, Please Click Here.

Thank you for choosing to partner with Sanofi Pasteur as your 2021-2022 influenza manufacturer of choice.

For additional support and information on Sanofi Pasteur’s 2021-2022 influenza vaccine offer, please contact your Sanofi Pasteur representative or call 1-800-VACCINE (1-800-822-2463). All reservations are subject to Sanofi Pasteur’s Terms and Conditions of Sale in effect at the time of reservation confirmation, including credit review. Copies of which are available upon request or by logging on to VaccineShoppe.com.